CS logo
small CS logo
LA Universal Research Center, INC

Los Angeles, California, United States
Doctor in Los Angeles, California
820 S Alvarado St, Los Angeles, CA 90057

About LA Universal Research Center, INC


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
AOBiome LLC
2
Asana BioSciences
2
Bristol-Myers Squibb
2
Alfasigma S.p.A.
1
Enanta Pharmaceuticals, Inc
1
Galapagos NV
1
Senseonics, Inc.
1
Total Rows: 8

Clinical Trials at LA Universal Research Center, INC


During the past decade, LA Universal Research Center, INC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44334422110000001144Started TrialsCompleted Trails201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
2018-07-05
2019-08-14
Completed
244
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
2018-07-26
2020-11-30
Completed
1,020
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
2018-09-29
2019-09-09
Terminated
168
A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis
2018-12-07
2019-06-10
Completed
28
A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis
2019-03-25
2020-02-27
Terminated
33
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
2019-08-12
2026-07-26
Active, not recruiting
1,452
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis
2019-10-29
2022-04-28
Completed
445
Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.
2020-02-03
2021-09-16
Completed
228

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "LA Universal Research Center, INC" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "AOBiome LLC" with 2 trials sponsored, "Asana BioSciences" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Alfasigma S.p.A." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "LA Universal Research Center, INC" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "bioRASI, LLC" with 2 trials as a collaborator and "Novella Clinical" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at LA Universal Research Center, INC


According to Clinical.Site data, the most researched conditions in "LA Universal Research Center, INC" are "Atopic Dermatitis" (9 trials), "Psoriasis" (2 trials), "COVID-19" (1 trials), "Diabetes" (1 trials) and "Eczema" (1 trials). Many other conditions were trialed in "LA Universal Research Center, INC" in a lesser frequency.

Clinical Trials Intervention Types at LA Universal Research Center, INC


Most popular intervention types in "LA Universal Research Center, INC" are "Drug" (9 trials), "Biological" (4 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Lebrikizumab" (4 trials), "ASN002" (2 trials), "BMS-986165" (2 trials) and "Apremilast" (1 trials). Other intervention names were less common.

Clinical Trials Genders at LA Universal Research Center, INC


The vast majority of trials in "LA Universal Research Center, INC" are 14 trials for "All" genders.

Clinical Trials Status at LA Universal Research Center, INC


Currently, there are NaN active trials in "LA Universal Research Center, INC". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in LA Universal Research Center, INC, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in LA Universal Research Center, INC, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status